Antonia Caroli

Combining 3-D Quantitative Structure−Activity Relationship with Ligand Based and Structure Based Alignment Procedures for<i>in Silico</i>Screening of New Hepatitis C Virus NS5B Polymerase Inhibitors

Ira Musmuca, Antonia Caroli, Antonello Mai et al. · Journal of Chemical Information and Modeling · 2010 · 56 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition

Antonia Caroli, Silvia Simeoni, Rosalba Lepore et al. · Biochemical and Biophysical Research Communications · 2011 · 43 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin₇ (5-HT₇) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo

Enza Lacivita, Daniela Patarnello, Nikolas Stroth et al. · Journal of Medicinal Chemistry · 2012 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Hsp90 Inhibitors, Part 2: Combining Ligand-Based and Structure-Based Approaches for Virtual Screening Application

Antonia Caroli, Flavio Ballante, Richard B. Wickersham et al. · Journal of Chemical Information and Modeling · 2014 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

CYP19 (aromatase): Exploring the scaffold flexibility for novel selective inhibitors

Sabrina Castellano, G. STEFANCICH, Rino Ragno et al. · Bioorganic & Medicinal Chemistry · 2008 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14